A Study of Oral Ibogaine in Opioid Withdrawal
Condition: Opiate Withdrawal Syndrome Interventions: Drug: DMX-1002; Drug: Placebo Sponsors: DemeRx IB, Inc.; MAC Clinical Research; ERT: Clinical Trial Technology Solutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2021 Category: Research Source Type: clinical trials